Skip to main content
Wolters Kluwer - PMC COVID-19 Collection logoLink to Wolters Kluwer - PMC COVID-19 Collection
letter
. 2022 Apr 8;41(5):e249–e251. doi: 10.1097/INF.0000000000003482

Features of COVID-19 in Children During the Omicron Wave Compared With Previous Waves in Madrid, Spain

Alfredo Tagarro 1, Olga-Nerea Coya 2, Ana Pérez-Villena 3, Beatriz Iglesias 3, Adriana Navas 4, David Aguilera-Alonso 5,, Cinta Moraleda 6
PMCID: PMC8997014  PMID: 35333818

To the Editors:

The SARS-CoV-2 variant Omicron (B.1.1.529) replaced other variants in Spain during the sixth wave, accounting for 79%–94% of positive samples in the last 2 weeks of 2021.1 The information is scarce about Omicron severity in children.

To describe the features of children with COVID-19 during the Omicron wave, we reviewed charts from children with COVID-19 attended at the emergency room of a secondary center in Spain from December 20, 2021, to January 2, 2022. All patients’ charts were reviewed 1 week after diagnosis to check complications.

The detection by reverse transcriptase-polymerase chain reaction (RT-PCR) used as target genes ORF1ab and N of the SARS-CoV-2 genome. All samples with a cycle threshold (Ct) <25 were analyzed with a second RT-PCR with probes targeting the gen S mutations consistent with Omicron. This study is part of the study EPICO-AEP.2

A total of 1,360 children were attended at the emergency room during the study period. Globally, 94 (6.9%) had a positive RT-PCR for SARS-CoV-2, with a median age of 6.5 years (interquartile range: 1.3–9.7), and 82.9% had fever. Of them, 15 (16.0%) had a Ct <25: 13/15 (86.7%) were identified as Omicron and 2/15 (13.3%) as Delta variant.

Only 2 of 94 (2.1%) patients were hospitalized: a 3-year-old girl with features of bacterial pneumonia and confirmed Omicron variant, and a 40-day-old infant with whooping cough. No patient needed pediatric intensive care unit admission or died. In a study performed by our group during the third wave, caused predominantly by the Alpha variant, 3/75 (4.0%) children with COVID-19 were hospitalized, not differently to the Omicron wave (P = 0.394), and one child needed pediatric intensive care unit admission.

To better describe the profile of children with Omicron, we identified 17 further children with Omicron attended at another center. We compared the features of the 109 ambulatory children attended during the Omicron wave in these 2 centers to 546 ambulatory children attended in previous waves in 35 centers, from March 2020 to October 2021, included in the national COVID-19 EPICO-AEP registry (Table 1).2 During the Omicron wave, more children presented upper respiratory tract infection, but fewer children had pneumonia. Fever, headache, and diarrhea were more common during the Omicron wave.

TABLE 1.

Comparison Between Features of Ambulatory Children Attended During the Omicron Wave and Previous Waves at the Emergency Rooms

Features Previous Waves N = 546 (%) Omicron Wave N = 109 (%) P
Sex (female) 289 (52.9%) 60 (55.0%) 0.686
Age (yrs), median (IQR) 5.7 (1.1–11.7) 6.6 (1.3–9.8) 0.330
Age band (yrs) <0.001
 0–4 259 (47.4%) 47 (43.1%)
 5–12 162 (29.7%) 54 (49.5%)
 12 or above 125 (22.9%) 8 (7.3%)
Comorbidity 99 (18.1%) 12 (11.0%) 0.070
Contact with household confirmed case 240 (44.0%) 33 (30.3%) 0.008
Symptoms/signs
 Fever 371 (67.9%) 90 (82.6%) 0.002
 Cough 264 (48.4%) 61 (56.0%) 0.147
 Sore throat 99 (18.1%) 20 (18.3%) 0.957
 Runny nose 197 (36.1%) 49 (45.0%) 0.081
 Fatigue, malaise 73 (12.2%) 12 (11.0%) 0.728
 Wheezing 23 (4.2%) 2 (1.8%) 0.237
 Headache 88 (16.1%) 35 (32.1%) <0.001
 Myalgia 48 (8.8%) 4 (3.7%) 0.071
 Diarrhea 75 (13.7%) 23 (21.1%) 0.049
 Vomiting 91 (16.7%) 23 (21.1%) 0.265
Syndromic diagnosis*
 Upper respiratory tract infection 195 (37.0%) 73 (67.0%) <0.001
 Flu-like 80 (15.2%) 14 (12.8%) 0.532
 Fever without a source 84 (15.9%) 5 (4.6%) 0.002
 Gastroenteritis 40 (7.6%) 7 (6.4%) 0.671
 Pneumonia 38 (7.2%) 1 (0.9%) 0.013
 Asymptomatic 44 (8.3%) 3 (2.8%) 0.042
 Bronchitis/asthma flare 18 (3.4%) 2 (1.8%) 0.389
 Bronchiolitis 2 (0.4%) 0 (0.0%) 0.519

Categorical variables are compared using the χ2 or Fisher tests, and continuous variables using Wilcoxon rank-sum test. Significant P values (<0.05) are in bold.

*

The syndromic diagnosis was not recorded in 19 cases diagnosed in previous waves; percentages and P values are calculated omitting those cases.

Notably, most patients during the Omicron wave were ≤11 years old. Nearly 83% of adolescents ≥12 years old are vaccinated in Spain, which may explain the low proportion of adolescents in our population. Some studies reported that around 1%–2% of children with COVID-19 need hospitalization, likewise our study.3,4

This study suggests that children with the Omicron variant do not have a worse outcome than children with previous variants. Omicron in children seemed to have a similar clinical profile but with increased tropism for the upper airway and less tropism for the lungs.

ACKNOWLEDGMENTS

We thank all the patients and families for their participation in this cohort, the staff members who cared for them at their personal risk in this time of epidemics and pediatricians who cared for the patients and helped gathering data including: Teresa Reinoso, Alfonso Cañete and Ane Plazaola (Hospital Universitario Infanta Sofía), David Melero, Angela Somodevilla and Raquel Guillén (UR Salud).

Footnotes

This study is funded by Project PI20/00095, from the Instituto de Salud Carlos III (Ministry of Economy, Industry and Competitiveness), and cofounded by the European Regional Development Fund; and by SERMAS-Fundación para la Investigación Biomédica del Hospital 12 de Octubre. D.A.-A. is supported by a specific Research Project of the Spanish Society of Paediatrics (Asociación Española de Pediatría); Grant Covid-19 EPICO-AEP 2020.

The authors have no conflicts of interest to disclose.

A.T. conceptualized and designed the study. A.T., A.P.-V., B.I., and A.N. performed the data management. A.T. and D.A.-A. performed the statistical analysis. A.T., D.A.-A., and C.M. drafted the article. All coauthors enrolled participants and participated in the collection of data. All coauthors were involved in the preparation and review of the final article.

REFERENCES


Articles from The Pediatric Infectious Disease Journal are provided here courtesy of Wolters Kluwer Health

RESOURCES